New knowledge for omarigliptin tablets: dissolution assay -behavior in different media and biopharmaceutical classification
Abstract: Omarigliptin (OMG) is an active substance for the treatment of type 2 diabetes and it is representing of the dipeptidyl peptidase IV inhibitors class, an important enzyme in the regulation of blood glucose. It was launched on the Japanese market in 2015 as a weekly dose innovation. The ai...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidade Federal do Rio Grande do Sul
2024-01-01
|
| Series: | Drug Analytical Research |
| Subjects: | |
| Online Access: | https://seer.ufrgs.br/Po/index.php/dar/article/view/136825 |